We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitlePhase III randomized trial of docetaxel-carboplatin versus paclitaxel-carboplatin as first-line chemotherapy for ovarian carcinoma.AuthorsVasey PA; Jayson GC; Gordon A; Gabra H; Coleman R; Atkinson R; Parkin D; Paul J; Hay A; Kaye SBPublicationJournal of the National Cancer Institute, 2004, Vol 96, Issue 22, p1682ISSN1460-2105Publication typearticleDOI10.1093/jnci/djh323